![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Selective removal of lateral olivocochlear efferents increases vulnerability to acute acoustic injury 1Eaton-Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA 02114 2Department of Otology and Laryngology, Harvard Medical School, Boston, MA 02114 3Program in Speech and Hearing Bioscience and Technology, Division of Health Science and Technology, Harvard and MIT, Cambridge, MA Corresponding Author: M. Charles Liberman, Ph. D. Eaton-Peabody Laboratory 243 Charles Street Massachusetts Eye and Ear Infirmary Boston, MA 02114 Phone: 617-573-3745 FAX: 617-720-4408 Email: Charles_Liberman/at/meei.harvard.edu The publisher's final edited version of this article is available free at J Neurophysiol. See commentary "Role for the lateral olivocochlear neurons in auditory function. Focus on "Selective removal of lateral olivocochlear efferents increases vulnerability to acute acoustic injury"." in J Neurophysiol, volume 97 on page 963. See other articles in PMC that cite the published article.Abstract Cochlear sensory cells and neurons receive efferent feedback from the olivocochlear (OC) system. The myelinated medial component of the OC system, and its effects on outer hair cells (OHCs), has been implicated in protection from acoustic injury. The unmyelinated lateral (L)OC fibers target ipsilateral cochlear nerve dendrites, and pharmacological studies suggest the LOC's dopaminergic component may protect these dendrites from excitotoxic effects of acoustic overexposure. Here, we explore LOC function in vivo via selective stereotaxic destruction of LOC cell bodies in mouse. Lesion success in removing the LOC, and sparing the MOC, was assessed by histological analysis of brainstem sections and cochlear whole-mounts. Auditory brainstem responses (ABR), a neural-based metric, and distortion product otoacoustic emissions (DPOAEs), an OHC-based metric, were measured in control and surgical mice. In cases where the LOC was at least partially destroyed, there were increases in suprathreshold neural responses that were frequency- and level-independent, and not attributable to OHC-based effects. These interaural response asymmetries were not found in controls, or in cases where the lesion missed the LOC. In LOC-lesion cases, after exposure to a traumatic stimulus, temporary threshold shifts were greater in the ipsilateral ear, but only when measured in the neural response; OHC-based measurements were always bilaterally symmetric, suggesting OHC vulnerability was unaffected. Interaural asymmetries in threshold shift were not found in either unlesioned controls or in cases which missed the LOC. These findings suggest that the LOC modulates cochlear nerve excitability and protects the cochlea from neural damage in acute acoustic injury. Keywords: Cochlea, Excitotoxicity, Noise-induced hearing loss, Feedback control Introduction Vertebrate hair cell systems, including the cochlea, vestibular organs and lateral line, are modulated by efferent feedback (for review, see Guinan 1996). In the mammalian cochlea, efferent feedback is provided by the olivocochlear (OC) bundle, which comprises two components (Figure 1A,B
MOC terminals on OHCs are cholinergic, and when activated, suppress cochlear responses by decreasing the normal contribution of OHCs to amplification of cochlear mechanical vibrations (for review, see Guinan 1996). LOC terminals are more complex cytochemically, with immunohistochemical evidence for cholinergic, GABAergic, dopaminergic and peptidergic transmission (for review see Eybalin 1993). Morphological studies suggest two LOC subgroups based on cell-body location and extent of peripheral ramification (Brown 1987; Warr et al. 1997). Immunohistochemistry suggests a corresponding cytochemical dichotomy between a cholinergic/GABAergic and a dopaminergic subgroup (Darrow et al. 2006a). Consistent with the observation that LOC activation, via inferior colliculus stimulation, can evoke either slow enhancement or suppression of auditory nerve response (Groff and Liberman 2003), it can be hypothesized that the former effect stems from the cholinergic subgroup, and the latter effect from the dopaminergic subgroup. Many studies have implicated OC feedback in protecting the cochlea from acoustic injury: electrical stimulation of the OC bundle reduces temporary threshold shifts from acoustic overexposure (Rajan 1988; Reiter and Liberman 1995), and chronic section of the OC bundle renders the ear more vulnerable to permanent acoustic injury (Handrock and Zeisberg 1982; Kujawa and Liberman 1997). Although OC contributions to protection are well documented, ambiguity remains as to the relative contributions of LOC vs. MOC systems, given that: 1) LOC and MOC axons run together in the OC bundle, thus both electrical stimulation and surgical section experiments could theoretically involve both systems, and 2) both LOC and MOC systems have cholinergic components, thus the pharmacological blockers used may not be selective. The most definitive evidence for a protective effect of the cholinergic MOC system is the observation that mice with over-expression of 9 cholinergic receptors in OHCs have enhanced resistance to permanent and temporary acoustic injury (Maison et al. 2002). Although no direct evidence exists for an LOC protective role, it has been suggested (e.g. Ruel et al. 2001) that one LOC function is controlling what appears to be glutamate excitotoxicity in afferent nerve terminals in the acute stages of acoustic injury (Liberman and Mulroy 1982; Robertson 1983; d'Aldin et al. 1995; Puel et al. 1998): cochleas perfused with dopamine antagonists show vacuolization of cochlear terminals which mimic that seen after acoustic overexposure (Ruel et al. 2001), and infusion of a dopamine agonist prior to noise exposure reduced the extent of threshold shift and the amount of neural swelling (d'Aldin et al., 1995). To directly assess the contribution of the LOC system to protection, we stereotaxically lesioned LOC neurons (Le Prell et al. 2003) in adult mice and compared noise-induced threshold shifts following binaural noise exposure in the ears ipsilateral and contralateral to the lesion. The integrity of the MOC pathway was verified both morphologically (in the brainstem and cochlea) and functionally (with bilateral measurement of MOC-mediated suppression of cochlear responses). In animals with unilateral LOC lesions, the ear ipsilateral to the lesion showed larger threshold shifts than the contralateral ear, but only when measured via the cochlear neural responses (ABR Wave 1); threshold shifts measured by OHC based responses (otoacoustic emissions) remained bilaterally symmetric. Results are consistent with an LOC-mediated protection of the cochlear nerve dendrites during acoustic overexposure. Materials and Methods Stereotaxic Surgery All procedures were approved by the IACUC of the Massachusetts Eye and Ear Infirmary. Experimental animals were CBA/CaJ mice of either sex aged 6-8 weeks, weighing between 25-30g. Following anesthesia with xylazine (20 mg/kg i.p.) and ketamine (100 mg/kg i.p.), the mouse was held in a Kopf small-animal stereotaxic apparatus by snout clamp and ear bars. The skin overlaying the skull was slit and retracted to reveal the bregma and lambdoidal sutures. Rongeurs were used to make an opening in the skull over the right lambdoidal suture. Using coordinates modified from Franklin and Paxinos (1997), a micropipette filled with a 10 mM solution of the cytotoxin melittin (in saline) was lowered into the brain at a position 0.49 mm caudal and 0.12 mm lateral to the bregma. When a depth of 0.69 mm was reached, 2 μl of solution was injected via a 10 μl syringe (Hamilton) coupled to the micropipette. Immediately after injection, the scalp was sutured, and the animal placed in a padded cage with heat lights for ~1 hr post surgery. A total of 18 mice underwent surgery. Animals in which the injection missed the target (see below) served as surgical controls, and 8 mice without surgery were included as an additional control. ABR and DPOAE Measurements Both ABRs and DPOAEs were recorded at 2 and 4 wks post-surgery, and again 6 hrs and 1 wk post-acoustic overexposure. For ABRs and DPOAE recordings, mice were anesthetized with ketamine and xylazine (same dose as for surgery), and needle electrodes were inserted at the vertex and pinna. The ABR was evoked with 5-ms tone pips (0.5-ms rise–fall, with a cos2 envelope, at 35/sec). The response was amplified (10,000x), filtered (0.1–3 kHz), and averaged with a digital I-O board in a PC-based data-acquisition system. Acoustic stimuli were delivered through a closed acoustic coupler housing two electrostatic drivers as sound sources (TDT EC-1, Tucker Davis Technologies) and one electret microphone (Knowles) at the end of a probe tube to measure sound pressures in situ. Sound level was raised in 5-dB steps from 0 to 80 dB SPL. At each level, 1,024 responses were averaged (with stimulus polarity alternated) after ‘artifact rejection’. Threshold was determined by visual inspection. DPOAEs at 2f1-f2 were recorded in response to primary tones: f1 and f2, with f2/f1 = 1.2 and f2 level 10 dB < f1 level. FFTs were computed and averaged over 5 waveform traces, and 2f1-f2 DPOAE amplitude and surrounding noise floor were extracted. Iso-response contours were interpolated from plots of amplitude vs. sound level, performed in 5 dB steps of primary level. “Threshold” is defined as the primary level (f2) required to produce a DPOAE at 0 dB SPL. Acoustic Overexposure Animals were acoustically over-exposed at 5 wks post-surgery. The animals were exposed free-field, awake and unrestrained, in a small reverberant chamber. Acoustic trauma consisted of a 15-minute exposure to an 8-16 kHz octave band noise presented at 94 dB SPL. Exposure level was measured at four positions inside the cage and varied by < 0.5 dB. Medial Olivocochlear (MOC) Assay MOC assays were performed on 6 control animals (no surgery and no acoustic exposure) and a randomly chosen subset (n=12) of the experimental animals (at least 1 wk after the exposure to noise). Animals were anesthetized as for ABR and DPOAE testing, and a posterior craniotomy and partial cerebellar aspiration exposed the floor of the IVth ventricle. Shocks (monophasic 150 μsec pulses at 200/sec) were applied through silver wires at the midline. Shock threshold for facial twitch was determined, paralysis induced with α-d-tubocurarine (1.25 mg/kg i.p.), and the animal connected to a respirator. Shock levels were raised 6 dB above twitch threshold. The MOC suppression effects on DPOAEs were then assessed in both cochleae. f2 level was set to produce a DPOAE ~10 dB > noise floor. Repeated measures of baseline DPOAE amplitude (n=12) were made prior to a series of 17 contiguous periods in which DPOAE amplitudes were repeatedly measured during a continuous 70-sec shock train to the OC bundle. The shock epoch was followed by a series of DPOAE amplitude measurements (n=36) to observe the extinction of the MOC effect. Histological Preparation After final testing (~7 wks post-surgery), animals were perfused intracardially with 10% formalin. The brainstems were extracted, post-fixed overnight, cryoprotected in sucrose, frozen and cut on a sliding microtome at 80 μm in the transverse plane. Slide-mounted sections were stained for acetylcholinesterase (AChE) activity to allow for visualization of the cholinergic OC cells in the brainstem (Osen and Roth 1969), as well as to verify that the microelectrode pipette did not sever the OC bundle. Cochleas on both sides were extracted, post-fixed overnight, decalcified in EDTA for ~48 hrs, dissected into half-turn segments and double immunostained for cholinergic and dopaminergic markers: rabbit anti-VAT (vesicular acetylcholine transporter; Sigma catalog #V5387, at 1:1000) and sheep anti-TH (tyrosine hydroxylase; from Calbiochem, catalog #657014, at 1:500), respectively. Primaries were followed by a species-appropriate fluorophore-coupled secondary at 1:1000 (VAT - Alexafluor 568, TH - Alexafluor 488). Morphometric Analysis Brainstems The location, size and success of the brainstem lesion were quantified by comparing the area of the lateral superior olive (LSO) on both sides of the brainstem. A drawing tube was used to trace the outline of surviving LSO cells in all sections from its caudal to rostral extreme. Tracings were digitized, and the areas of both medial and lateral limbs were determined by computerized planimetry. Cochleas Cochlear location was converted to frequency (Muller et al. 2005), and 10 log-spaced frequency loci were identified in each case. At each locus in each case, an observer blind to the physiology and brainstem analyses separately rated the innervation densities of VAT- and TH-positive terminals in both the inner and outer hair cell areas. A 3-point scale was used for VAT-positive terminals in the OHC area: the observer's task was to estimate the fraction of OHCs with at least one VAT-positive terminal: 3 = 100-67%, 2 = 66-34%, and 1 = 33-0%. VATand TH-positive terminals in the IHC area were evaluated with a 4-point scale: 3 = profuse, 2 = moderate, 1= sparse and 0 = none. Each immunostain was separately referenced to its own maximum values: i.e. TH-positive terminals are much rarer than VAT terminals, but maximum density for each would receive a rating “3”. To normalize the data, the cochlear spiral dimension was divided into 10 equal frequency bins; within each bin, ratings from all contralateral ears were averaged for each area (IHC vs OHC) and for each immunostain (TH vs VAT). Then, all values, whether from contra or ipsi ears, were referenced to the maximum mean value across all frequency bins for that area and for that immunostain. Further details can be found in the caption of Figure 3
Results A. Histological assessment of completeness and selectivity of the LOC lesion Brainstems and cochlear whole mounts were evaluated to assess the completeness and selectivity of the lesions, i.e. the extent to which they were successful in eliminating the LOC system and sparing the MOC system and the stapedius muscle reflex. 1. Brainstems When the cytotoxin (melittin) successfully targeted the LSO, there was a clear loss of cholinergic neurons from the LSO area and a clear disruption of the LSO neuropil. The paired micrographs in Figures Figures2A2A
When estimating the extent of lesion success on the LOC cell bodies, it is also important to assess, in both the Hit and Miss cases, which others structures were damaged. In particular the extent of MOC involvement is key to interpreting the results. As schematized in Figure 4
In addition to the MOC system, the innervation of the stapedius muscle also needs to be assessed, given that the stapedius reflex has also been implicated in cochlear protection (Henderson et al. 1994; Ryan et al. 1994). Retrograde labeling of stapedius motorneurons in rat (Shibayama et al. 1990) show a majority population of neurons in the ipsilateral brainstem ventro-medial to the facial nucleus, and a minority population (~6%) scattered more rostrally near the facial nerve exit from the brainstem. Assuming that stapedius motorneurons are similarly located in mouse, the lesion in some hit cases may have included some stapedius motorneurons near the facial nerve exit (Fig. 4A 2. Cochleas Consistent with cochlear projections and laterality of LOC and MOC systems (Fig. 1A
B. Correlating Cochleas and Brainstems Considered individually, each case classified as LSO Hit based on the brainstem sections (Fig. 3A On a case-by case-basis, there was a good correlation between the brainstem and cochlear data with respect to MOC involvement. As shown in Figure 5D C. Functional Integrity of the MOC System In addition to assessing the morphological integrity of the MOC system, we assessed MOC function by electrically stimulating the OC bundle at the midline and while recording suppression of distortion product otoacoustic emissions (DPOAEs) in both ears. DPOAEs are distortions produced and amplified by normal healthy OHCs, which are propagated as mechanical vibrations back through the middle ear to the ear canal, where they can be measured in the sound pressure waveform. Because activation of the MOC feedback system essentially turns down the gain of the OHC electromechanical amplifier (Murugasu and Russell 1996; Cooper and Guinan 2003), the suppression of DPOAEs provides a rapid and reliable assay of MOC activation level. The maximum effect of MOC stimulation on DPOAE amplitude is for primary tones near 22.6 kHz (Maison et al. 2002, 2003), thus we show data only for 22.6 kHz (Fig. 6
The bilateral symmetry of MOC effect size did not differ significantly in control vs. injected cases (Fig. 6 D. Effect of LOC lesion on cochlear threshold and supra-threshold responses Cochlear thresholds, as measured by either auditory brainstem responses (ABRs) or DPOAEs, were unaffected by the LOC lesions: mean values were not significantly different between ears or lesion-success groups (Fig. 7A-D
In LOC Hit cases, mean ABR amplitudes were enhanced in the ipsilateral ear (Fig. 8A E. Effect of LOC lesion on vulnerability to acoustic injury Dendritic vacuolization in the IHC area, the morphological sign of glutamate excitotoxicity, is only seen in the acute stages (<24 hours) of acoustic injury (Liberman and Mulroy 1982; Robertson 1983; Puel et al. 1998); thus, we designed an exposure stimulus (94 dB at 8-16 kHz for 15 min) to create a moderate (~35 dB) threshold shift when tested 6 hrs post-exposure (Fig. 9A,B
Following exposure, threshold shifts in the LOC Miss cases were bilaterally symmetrical at 6 hrs post exposure, whether measured by ABRs (Fig. 9A,C In contrast, in the LOC Hit cases, the ABR threshold shifts were significantly larger in the ipsilateral ear when compared to either the contralateral ear or either of the LOC Miss ears (Fig. 9A,C Discussion A. Peripheral effects of the LOC system in modulating neural excitability Peripheral effects of the LOC system have been studied by electrical stimulation, pharmacological or genetic manipulation of transmitter/receptor combinations, and surgical lesion (see below). In these studies, LOC effects are characterized by level-independent, and frequency independent changes in cochlear neural evoked potentials without corresponding alterations in OHC-based responses such as cochlear microphonics or DPOAEs (e.g. Groff and Liberman, 2003; Le Prell et al., 2003). A similar constellation of effects is reported here after selective LOC lesion (e.g. Figure 8 The complex cytochemistry and pharmacology of the LOC system make it difficult to predict the effects of its removal. Activating the LOC pathway via electrical stimulation of the inferior colliculus suggests there are two functional subsystems capable of eliciting slow suppressive or excitatory effects on cochlear nerve activity (Groff and Liberman 2003). Correspondingly, the LOC system is cytochemically heterogeneous: co-localization studies suggest that a majority population of cholinergic cells also contain GABA, while a minority population is dopaminergic (Darrow et al. 2006a). There is also immunohistochemical evidence for peptide transmitters (urocortin, CGRP and opioids) in LOC terminals: although evidence is incomplete, these transmitters may also co-localize in the cholinergic terminals (see Eybalin 1993 for review). Pharmacological studies with agonists and antagonists of putative LOC neurotransmitters have suggested both excitatory and inhibitory effects on cochlear nerve activity. Cochlear perfusion of certain opioid agonists enhance cochlear nerve gross potentials (Sahley et al., 1991). ACh perfusion increased both spontaneous and glutamate-induced spiking (Felix and Ehrenberger 1992). In contrast, GABA did not affect spontaneous activity, but decreased glutamate-induced, and ACh-induced activity (Felix and Ehrenberger 1992; Arnold et al. 1998), while dopamine decreased both spontaneous and sound-driven activity (d'Aldin et al. 1995; Oestreicher 1997; Ruel et al. 2001). CGRP application increased spontaneous rates, and decreased mechanically driven rates, of primary afferents in the lateral line (Bailey and Sewell 2000). Conversely, targeted gene deletion of CGRP in mice decreased suprathreshold neural responses, without corresponding changes in DPOAE amplitudes (Maison et al. 2003). Previous lesion studies have taken four approaches to studying LOC function: 1) cut the entire OC bundle, thereby interrupting both MOC and LOC fibers (e.g. Liberman 1990; Zheng et al. 1999); 2) cut only the crossed OC bundle, thereby interrupting 2/3 of the MOC while sparing the LOC (e.g. Kujawa and Liberman 1997); 3) stereotaxically lesion the LSO/LOC system (Le Prell et al. 2003); or 4) perfuse the cochlea with agents designed to selectively destroy one class of LOC neurons (Le Prell et al 2005). Data from the first two approaches suggest that the LOC can modulate spontaneous and sound-evoked discharge rates in cochlear nerve fibers without large effects on threshold or tuning (Liberman 1990; Walsh et al. 1998). In chinchillas, complete de-efferentation (approach 1) increased sound-driven discharge rates (Zheng et al. 1999), suggesting that resting tone in the LOC pathway tends to suppress sound-evoked responses, consistent with the post-lesion enhancement of ABR amplitudes seen here (Figure 8 The fact that LOC destruction in some experiments can increase, and in others decrease, neural excitability, may simply reflect the existence of multiple LOC subgroups with both excitatory and inhibitory effects on cochlear nerve response. If the balance between the resting activation levels, or relative sizes or degrees of co-localization, of different cytochemical subgroups is different in different species, or is differentially affected by different anesthetics, one might expect such qualitatively different effects of LOC destruction, especially when the destruction is subtotal, as in all the relevant experiments. Correspondingly, the possibility must be considered that there are species differences in the protective effects we have now documented in mouse. B. Acoustic injury and olivocochlear feedback OHC dysfunction plays a major role in the genesis of both temporary threshold shifts (TTSs) and permanent threshold shifts (PTSs): e.g. slow OHC depolarizations are well correlated with TTS magnitude (Cody and Russell 1985), and the loss of OHCs and/or damage to their stereocilia are well correlated with PTS magnitude (Liberman and Dodds 1984). A longstanding theory of MOC function is that it protects the cochlea from both TTS and PTS via its actions on OHCs (Handrock and Zeisberg 1982; Rajan 1988; Reiter and Liberman 1995; Kujawa and Liberman 1997; Maison and Liberman 2000; Maison et al. 2002). The idea has been supported by four types of experimental findings: 1) the degree of TTS is decreased when the OC bundle is electrically stimulated simultaneously with the acoustic overexposure (Rajan 1988), 2) in animals with chronic OC bundle section, including both MOC and LOC components, deefferented ears are more vulnerable to both TTS and PTS (Handrock and Zeisberg 1982; Kujawa and Liberman 1997); 3) the strength of the MOC reflex (measured as a acoustically driven suppression of DPOAE amplitude) is strongly correlated to vulnerability (Maison and Liberman 2000); and, most definitively, 4) transgenic mice with over-expression of the ACh receptor in OHCs show enhanced MOC effects coupled with enhanced resistance to both TTS and PTS (Maison et al. 2002). Although MOC-mediated cholinergic effects on OHCs can clearly reduce acoustic vulnerability, there are hints in previous lesion studies that some of the increased vulnerability seen after complete de-efferentation is attributable to loss of the LOC system. For example, when acoustic vulnerability was assessed in totally de-efferented guinea pigs, neurally derived threshold shifts were 10-15 dB higher than OHC-derived shifts (a disparity not present in normal noise-exposed animals), and vulnerability was not significantly affected by the midline lesion, which interrupts 2/3 of the MOC while sparing the LOC (Kujawa and Liberman 1997). However, this and other prior evidence linking the LOC system to protection from acoustic injury is indirect. Neuronal damage appears to play an important role in the genesis of noise-induced TTSs (Liberman and Mulroy 1982; Robertson 1983; Puel et al. 1998), and the targeting of cochlear neurons by the LOC system makes LOC-mediated protection from acoustic injury an attractive hypothesis. A common cochlear pathology seen in the first 24 hrs after acoustic overexposure is swelling of cochlear nerve dendrites in the IHC area (Liberman and Mulroy 1982; Robertson 1983; Puel et al. 1998). This type of dendritic swelling can also be observed in cochleas perfused with glutamate agonists, but without noise exposure (Puel et al. 1994). Furthermore, when noise is presented with simultaneous intra-cochlear perfusion of a glutamate antagonist, there is less threshold shift (after washout of the glutamate antagonist) and fewer vacuoles (Puel et al. 1998). These observations suggest that dendritic swelling is a type of excitotoxicity brought on by excessive release of glutamate from the IHC. The LOC's dopaminergic component is hypothesized to mediate this protective effect: a) dendritic vacuolizations in the IHC area have been observed in cochleas perfused with a dopamine antagonist (without exposure to intense noise; Ruel et al. 2001) and b) cochlear perfusion of dopamine agonists prior to noise exposure reduced the amount of noise induced threshold shift and ischemia-induced neuronal swelling (d'Aldin et al. 1995). Given that the LOC system targets IHCs as well as auditory nerve dendrites (Liberman et al. 1990), this LOC-mediated protection could be mediated presynaptically, e.g. by reducing glutamate release from the IHC, or it could result from post-synaptic modulation of the Ca++ entry known to mediate excitotoxicity in other systems. Previous work in our laboratory has documented the presence of IHC area vacuoles in mice with 40 dB of TTS, i.e. similar in magnitude to that produced in this study (Wang et al. 2002). The dramatic nature of dendritic swelling suggests that it should be accompanied by a loss of synaptic transmission between the IHC and cochlear nerve: electron microscopic images show loss of intracellular components from, and membrane rupture of, the post-synaptic afferent terminal (Robertson 1983; Puel et al. 1998; Ruel et al. 2001; Le Prell et al 2004). It follows that loss of synaptic transmission should contribute to the acute threshold shift, and that TTS should be larger in neural measures (e.g. ABRs) than in OHC-based measures (e.g. DPOAEs). In the present study, LOC lesions resulted in enhanced ABR threshold shifts re DPOAE threshold shifts, consistent with a significant component of “additional” TTS attributable to a dysfunction at the level of the inner hair cell or cochlear nerve. In contrast, mice with normal LOC innervation showed almost identical degrees of ABR and DPOAE shift (Fig. 9 If dendritic vacuolization is a functionally relevant contributor to TTS, why do ears with an intact LOC system show comparable ABR and DPOAE shifts (Mills 2003; Wang et al. 2002; Maison et al. 2003; Kujawa and Liberman 2006)?. In comparing ABR- and DPOAE-based threshold shifts it is important to consider the relative insensitivity of neural-based sound-evoked gross potentials such as ABRs to a distributed loss of neural elements. In adult chinchillas with selective IHC loss, which is functionally similar to primary neuronal degeneration as far as ABR generation is concerned, a distributed loss of 50% of the responding neurons in a particular cochlear region resulted in a neural-based gross potential shift of <6 dB (Liberman et al. 1997). This can be understood by considering that a sound level increase of 6 dB can double the discharge rate of individual cochlear neurons near threshold (e.g. Winter et al. 1990) and thereby compensate for the loss of half the responsive neural elements. This line of argument resolves the apparent paradox that significant numbers of dysfunctional-looking cochlear nerve dendrites can be observed in normal animals with TTS, without a significant degree of “additional” threshold shift in ABRs re DPOAEs. The insensitivity of neural-based metrics to distributed IHC loss, and subsequently to neural degeneration, also implies that the 10-15 dB of “additional” ABR shift observed in LOC-lesioned ears (Fig. 9 It has been suggested that OC-mediated protection is an epiphenomenon rather then a functional role that evolved because it confers selective advantage, given that the traumatic acoustic exposures used in “protection” experiments are well above levels that ever existed in the pre-industrial age (Kirk and Smith 2003). The present study uses sound pressures that are significantly lower than those used in previous studies of MOC protection (94 dB vs. ≥ 105 dB SPL) and thus makes it more plausible that anti-excitotoxicity is one of the functional roles of the LOC system, rather than an epiphenomenon. Furthermore, the incompleteness of the present lesions and the magnitude of the protective effect they reveal make it likely that significant protective effects may be present for exposures at even lower sound pressures. Acknowledgements Research supported by grants from the NIDCD: RO1 DC00188, P30 DC05209 and T32 DC0038. We gratefully acknowledge the generous assistance provided by Drs. S. Bledsoe and C. Le Prell in applying their stereotaxic injection techniques to the mouse. Footnotes 1In a larger sample of cases, summarized in a study of the LOC role in balancing bilateral neural excitability (Darrow et al. 2006b), a complementary reduction was seen in the ABR amplitudes in the contralateral ears of LOC Hit cases. We hypothesize that the lack of contralateral effects in the smaller subset of animals used in these acoustic injury experiments reflects (chance) differences in the degree to which the crossing ascending projections to the contralateral LSO were interrupted by the lesions. References Cited
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Physiol Rev. 1993 Apr; 73(2):309-73.
[Physiol Rev. 1993]J Comp Neurol. 1987 Jun 22; 260(4):605-18.
[J Comp Neurol. 1987]J Neurophysiol. 2003 Nov; 90(5):3178-200.
[J Neurophysiol. 2003]J Neurophysiol. 1988 Aug; 60(2):549-68.
[J Neurophysiol. 1988]J Neurophysiol. 1995 Feb; 73(2):506-14.
[J Neurophysiol. 1995]Arch Otorhinolaryngol. 1982; 234(2):191-5.
[Arch Otorhinolaryngol. 1982]J Neurophysiol. 1997 Dec; 78(6):3095-106.
[J Neurophysiol. 1997]J Neurosci. 2002 Dec 15; 22(24):10838-46.
[J Neurosci. 2002]Eur J Neurosci. 2001 Sep; 14(6):977-86.
[Eur J Neurosci. 2001]Hear Res. 1983 Mar; 9(3):263-78.
[Hear Res. 1983]Neuroreport. 1998 Jun 22; 9(9):2109-14.
[Neuroreport. 1998]J Assoc Res Otolaryngol. 2003 Jun; 4(2):276-90.
[J Assoc Res Otolaryngol. 2003]Brain Res. 1969 Nov; 16(1):165-85.
[Brain Res. 1969]Hear Res. 2005 Apr; 202(1-2):63-73.
[Hear Res. 2005]Hear Res. 1998 Feb; 116(1-2):43-54.
[Hear Res. 1998]Hear Res. 1988 Sep 15; 35(2-3):271-4.
[Hear Res. 1988]J Comp Neurol. 1993 Nov 22; 337(4):600-13.
[J Comp Neurol. 1993]Hear Res. 1994 Apr; 74(1-2):22-8.
[Hear Res. 1994]Hear Res. 1994 Jan; 72(1-2):23-8.
[Hear Res. 1994]Kaibogaku Zasshi. 1990 Jun; 65(3):120-33.
[Kaibogaku Zasshi. 1990]J Physiol. 2003 Apr 1; 548(Pt 1):307-12.
[J Physiol. 2003]J Neurosci. 2002 Dec 15; 22(24):10838-46.
[J Neurosci. 2002]J Comp Neurol. 2003 Jan 13; 455(3):406-16.
[J Comp Neurol. 2003]Hear Res. 1983 Mar; 9(3):263-78.
[Hear Res. 1983]Neuroreport. 1998 Jun 22; 9(9):2109-14.
[Neuroreport. 1998]J Neurophysiol. 2003 Nov; 90(5):3178-200.
[J Neurophysiol. 2003]J Assoc Res Otolaryngol. 2003 Jun; 4(2):276-90.
[J Assoc Res Otolaryngol. 2003]J Neurophysiol. 2003 Nov; 90(5):3178-200.
[J Neurophysiol. 2003]Physiol Rev. 1993 Apr; 73(2):309-73.
[Physiol Rev. 1993]Hear Res. 1991 Sep; 55(1):133-42.
[Hear Res. 1991]Hear Res. 1998 Nov; 125(1-2):147-53.
[Hear Res. 1998]Hear Res. 1997 May; 107(1-2):46-52.
[Hear Res. 1997]Hear Res. 1990 Nov; 49(1-3):209-23.
[Hear Res. 1990]J Comp Neurol. 1999 Mar 29; 406(1):72-86.
[J Comp Neurol. 1999]J Neurophysiol. 1997 Dec; 78(6):3095-106.
[J Neurophysiol. 1997]J Assoc Res Otolaryngol. 2003 Jun; 4(2):276-90.
[J Assoc Res Otolaryngol. 2003]J Assoc Res Otolaryngol. 2005 Mar; 6(1):48-62.
[J Assoc Res Otolaryngol. 2005]Nature. 1985 Jun 20-26; 315(6021):662-5.
[Nature. 1985]Hear Res. 1984 Oct; 16(1):55-74.
[Hear Res. 1984]Arch Otorhinolaryngol. 1982; 234(2):191-5.
[Arch Otorhinolaryngol. 1982]J Neurophysiol. 1988 Aug; 60(2):549-68.
[J Neurophysiol. 1988]J Neurophysiol. 1995 Feb; 73(2):506-14.
[J Neurophysiol. 1995]J Neurophysiol. 1997 Dec; 78(6):3095-106.
[J Neurophysiol. 1997]Hear Res. 1983 Mar; 9(3):263-78.
[Hear Res. 1983]Neuroreport. 1998 Jun 22; 9(9):2109-14.
[Neuroreport. 1998]J Comp Neurol. 1994 Mar 8; 341(2):241-56.
[J Comp Neurol. 1994]Eur J Neurosci. 2001 Sep; 14(6):977-86.
[Eur J Neurosci. 2001]J Comp Neurol. 1990 Nov 15; 301(3):443-60.
[J Comp Neurol. 1990]J Assoc Res Otolaryngol. 2002 Sep; 3(3):248-68.
[J Assoc Res Otolaryngol. 2002]Hear Res. 1983 Mar; 9(3):263-78.
[Hear Res. 1983]Neuroreport. 1998 Jun 22; 9(9):2109-14.
[Neuroreport. 1998]Eur J Neurosci. 2001 Sep; 14(6):977-86.
[Eur J Neurosci. 2001]J Acoust Soc Am. 2004 Aug; 116(2):1044-56.
[J Acoust Soc Am. 2004]J Acoust Soc Am. 2003 Feb; 113(2):914-24.
[J Acoust Soc Am. 2003]J Assoc Res Otolaryngol. 2002 Sep; 3(3):248-68.
[J Assoc Res Otolaryngol. 2002]J Neurophysiol. 2003 Nov; 90(5):2941-9.
[J Neurophysiol. 2003]Hear Res. 1990 May; 45(3):191-202.
[Hear Res. 1990]Eur J Neurosci. 2001 Sep; 14(6):977-86.
[Eur J Neurosci. 2001]Trends Pharmacol Sci. 2004 Jun; 25(6):317-24.
[Trends Pharmacol Sci. 2004]J Neurosci. 2005 Mar 23; 25(12):3041-5.
[J Neurosci. 2005]J Assoc Res Otolaryngol. 2003 Dec; 4(4):445-65.
[J Assoc Res Otolaryngol. 2003]Hear Res. 1988 Sep 15; 35(2-3):271-4.
[Hear Res. 1988]